@ungodlytrinity here’s a Springer Health Care Analysis article which goes into detail about it in the background https://t.co/FyVq38CW2R
RT @CAPA_Arthritis: NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence, 19…
RT @CAPA_Arthritis: NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence, 19…
"appraisal becomes a “rubber stamping exercise” to ratify judgements embedded in the rules, rather than an exercise in deliberative decision-making." Interesting viewpoint.
NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence, 1999–2018 https://t.co/vCND7HxOvR 2 complementary ethical frameworks- 1) procedural - accountability for reasonableness (AfR) 1/3
RT @felly500: NICE over 2 decades commitment to frameworks of ‘accountability for reasonableness’ & ‘ethics of opportunity costs’, 2 tre…
NICE over 2 decades commitment to frameworks of ‘accountability for reasonableness’ & ‘ethics of opportunity costs’, 2 trends 1 NICE’s approach to assessment has become more formalised. 2 NICE has become more lenient in its evidence requirements h
Not had the chance to read this yet but it sounds fascinating and my initial reaction is I couldn’t agree more. I found a similar direction of travel re:transparency across the appraisal programme as a whole. https://t.co/R894k8dY6V
RT @anetrid: Fantastic work by @VicCharlton @GHSMatKCL on @NICEComms approach to healthcare priority-setting over the years - with thanks t…
RT @pjwoodgate: How has the approach of the National Institute for Health and Care Excellence to new treatments changed over the last two d…
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @pash22: NICE and Fair? Health Technology Assessment Policy Under the UK’s @NICEComms , 1999–2018 https://t.co/y5rnFd3Pj4 via @VicCharlt…
NICE and Fair? Health Technology Assessment Policy Under the UK’s @NICEComms , 1999–2018 https://t.co/y5rnFd3Pj4 via @VicCharlton
RT @VicCharlton: NICE’s evolving approach to healthcare priority-setting may be undermining its commitment to fairness, evidence shows. New…
RT @pjwoodgate: How has the approach of the National Institute for Health and Care Excellence to new treatments changed over the last two d…
RT @ruairidhm: Important paper @VicCharlton about changes at NICE, suggesting that “existing interventions and NHS services are displaced t…
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @ruairidhm: Important paper @VicCharlton about changes at NICE, suggesting that “existing interventions and NHS services are displaced t…
RT @ruairidhm: Important paper @VicCharlton about changes at NICE, suggesting that “existing interventions and NHS services are displaced t…
RT @ruairidhm: Important paper @VicCharlton about changes at NICE, suggesting that “existing interventions and NHS services are displaced t…
RT @ruairidhm: Important paper @VicCharlton about changes at NICE, suggesting that “existing interventions and NHS services are displaced t…
RT @ruairidhm: Important paper @VicCharlton about changes at NICE, suggesting that “existing interventions and NHS services are displaced t…
RT @ruairidhm: Important paper @VicCharlton about changes at NICE, suggesting that “existing interventions and NHS services are displaced t…
RT @ruairidhm: Important paper @VicCharlton about changes at NICE, suggesting that “existing interventions and NHS services are displaced t…
Important paper @VicCharlton about changes at NICE, suggesting that “existing interventions and NHS services are displaced to fund the new, branded technologies that NICE typically appraises”
RT @pjwoodgate: How has the approach of the National Institute for Health and Care Excellence to new treatments changed over the last two d…
How has the approach of the National Institute for Health and Care Excellence to new treatments changed over the last two decades? @wellcometrust PhD student @VicCharlton explores what has happened in this fascinating open access article https://t.co/o1QA
@aheblog @ChrisSampson87 new @HCAnalysis paper on the evolution of NICE methods 1999-2018 and the ethical implications, in case it’s of interest for the weekly journal round up. https://t.co/wTCnpnvPtC
RT @kchalkidou: Almost 20 NICE years: NICE formalised its approach to assessment and deliberation over the years whilst also relaxing its r…
RT @VicCharlton: NICE is reviewing its methods for deciding which health technologies the #NHS should adopt. A welcome announcement given t…
RT @MrTrevMcCarthy: Timely analysis of NICE funding recommendations including internal processes & external factors https://t.co/iEcqhag1FW
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
RT @VicCharlton: Research suggests that weaker evidential requirements & more formalised approach to social value judgements may undermine…
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @VicCharlton: Research suggests that weaker evidential requirements & more formalised approach to social value judgements may undermine…
Timely analysis of NICE funding recommendations including internal processes & external factors
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
RT @VicCharlton: Research suggests that weaker evidential requirements & more formalised approach to social value judgements may undermine…
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
RT @VicCharlton: Research suggests that weaker evidential requirements & more formalised approach to social value judgements may undermine…
RT @ManuelaJoore: Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? H…
Evidence has been getting worse & evidential requirements more lenient: what could possibly go wrong...? NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence, 1999–2018 | SpringerLink https
Two countries separated by very different cultures: value/pricing/access decisions have become too "flexible" argues @VicCharlton undoing the goals for economic efficiency & reasonableness. In the US, we want flexibility and less structured decisions.
RT @VicCharlton: Research suggests that weaker evidential requirements & more formalised approach to social value judgements may undermine…
RT @VicCharlton: Research suggests that weaker evidential requirements & more formalised approach to social value judgements may undermine…
NICE is reviewing its methods for deciding which health technologies the #NHS should adopt. A welcome announcement given the worrying drift in its approach over recent years. https://t.co/R894k8dY6V #rationing #HTA https://t.co/N1IqSIVobS
RT @kchalkidou: Almost 20 NICE years: NICE formalised its approach to assessment and deliberation over the years whilst also relaxing its r…
RT @catherine_max: NICE and fair? @VicCharlton on 20 years of @NICEComms policy in practice shows increased leniency of its evidential requ…
NICE and fair? @VicCharlton on 20 years of @NICEComms policy in practice shows increased leniency of its evidential requirements. @felly500 @jimmcmanusph @MccabeCJM https://t.co/rCHGA9C61e
@NICEComms This is one of the most important papers I have read in a long time. It articulates many of the ethical concerns I and others have of NICE's CEA methods being softened in favour of the patients of interest at the expense of those patients bearin
RT @kchalkidou: Almost 20 NICE years: NICE formalised its approach to assessment and deliberation over the years whilst also relaxing its r…
RT @kchalkidou: Almost 20 NICE years: NICE formalised its approach to assessment and deliberation over the years whilst also relaxing its r…
Almost 20 NICE years: NICE formalised its approach to assessment and deliberation over the years whilst also relaxing its rules for dealing with evidence incl looser subgroup analyses, more indirect/non randomised evidence and lenience towards cancer techs
RT @JamesLomas88: A must-read for health economists! https://t.co/Y7jLxVpxZe
A must-read for health economists!
Research suggests that weaker evidential requirements & more formalised approach to social value judgements may undermine fairness of NICE decision-making. Open access. #HTA #WhoGetsWhatInTheNHS https://t.co/R894k8dY6V
RT @GlobalPHObserv: NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence htt…
Intéressant !! À lire !!
RT @Formindep: (open) 20 ans de dérive éthique et scientifique de l'évaluation des médicaments par le NICE (HAS britannique). Abaissement d…
RT @VicCharlton: @kchalkidou Quite. Especially in light of changes to NICE methods and question marks over the £30k (£50k) threshold. https…
Fantastic work by @VicCharlton @GHSMatKCL on @NICEComms approach to healthcare priority-setting over the years - with thanks to @wellcometrust @pjwoodgate @drdanoconnor
RT @Formindep: (open) 20 ans de dérive éthique et scientifique de l'évaluation des médicaments par le NICE (HAS britannique). Abaissement d…
RT @Formindep: (open) 20 ans de dérive éthique et scientifique de l'évaluation des médicaments par le NICE (HAS britannique). Abaissement d…
RT @meerpohl: NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence, 1999–201…
@kchalkidou Quite. Especially in light of changes to NICE methods and question marks over the £30k (£50k) threshold. https://t.co/R894k8dY6V
NICE’s evolving approach to healthcare priority-setting may be undermining its commitment to fairness, evidence shows. New (open access) paper in Health Care Analysis. #NHS #healthpolicy @anetrid @GHSMatKCL @wellcometrust funded https://t.co/R894k8d
RT @GlobalPHObserv: NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence htt…
NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence, 1999–2018 | SpringerLink https://t.co/MTeb6R8eoz
RT @GlobalPHObserv: NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence htt…
RT @GlobalPHObserv: NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence htt…
RT @Formindep: (open) 20 ans de dérive éthique et scientifique de l'évaluation des médicaments par le NICE (HAS britannique). Abaissement d…
RT @GlobalPHObserv: NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence htt…
NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence https://t.co/99YT8t1tXa
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @Formindep: (open) 20 ans de dérive éthique et scientifique de l'évaluation des médicaments par le NICE (HAS britannique). Abaissement d…
RT @Formindep: (open) 20 ans de dérive éthique et scientifique de l'évaluation des médicaments par le NICE (HAS britannique). Abaissement d…
(open) 20 ans de dérive éthique et scientifique de l'évaluation des médicaments par le NICE (HAS britannique). Abaissement du niveau de preuve exigé, voire inversion de la charge de la preuve pour les traitements du cancer, présumés efficaces. https://t.co
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
RT @hildabast: NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @V…
NICE's evolution has made it slowly, methodically, drift away from societal fairness & transparent value judgment, argues @VicCharlton: https://t.co/0B00yDsyWJ (Mixed methods study). A must-read for anyone interested in @NICEComms in particular, or HT